Regulation of matrix metalloproteinase expression in tumor invasion

FASEB Journal

Volumn 13, Issue 8, 1999, Pages 781-792

  Westermarck, Jukka ^a   Kähäri, Veli Matti ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Extracellular matrix; Interleukin; MMPs; SCC; Tissue inhibitors

Indexed keywords

CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER INVASION; CELL CONTACT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 0345643514     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.8.781     Document Type: Article

References (115)

1. Kähäri, V.-M., and Saarialho-Kere, U. (1997) Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213
2. Shapiro, S. D. (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10, 602-608
3. Woessner, J. F. (1998) The matrix metalloproteinase family. In Matrix Metalloproteinases. (Parks, W. C., and Mecham, R. P., eds) pp. 1-14, Academic Press, San Diego
4. Basset, P., Okada, A., Chenard, M.-P., Kannan, R., Stoll, I., Anglard, P., Bellocq, J.-P., and Rio, M.-C. (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 15, 535-541
5. Johnsen, M., Lund, L. R., Romer, J., Almholt, K., and Danø, K. (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10, 667-71
6. Hanemaaijer, R., Sorsa, T., Konttinen, Y. T., Ding, Y., Sutinen, M., Visser, H., van Hinsbergh, V. W., Helaakoski, T., Kainulainen, T., Ronka, H., Tschesche, H., and Salo, T. (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J. Biol. Chem. 272, 31504-31509
7. Knäuper, V., Cowell, S., Smith, B., López-Otín, C., O'Shea, M., Morris, H., Zardi, L., and Murphy, G. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem. 272, 7608-7616
8. Johansson, N., Saarialho-Kere, U., Airola, K., Herva, R., Nissinen, L., Westermarck, J., Vuorio, E., Heino, J., and Kähäri, V.-M. (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208, 387-397
9. Ståhle-Bäckdahl, M., Sandstedt, B., Bruce, K., Lindahl, A., Jimenez, M. G., Vega, J. A., and López-Otín, C. (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76, 717-728
10. Lindy, O., Konttinen, Y. T., Sorsa, T., Ding, Y., Santavirta, S., Ceponis, A., and López-Otín, C. (1997) Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arth. Rheum. 40, 1391-1399
11. Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A.-L., Karjalainen-Lindsberg, M.-L., Kähäri, V.-M., and Saarialho-Kere, U (1997) Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109, 96-101
12. Vaalamo, M., Karjalainen-Lindsberg, M. L., Puolakkainen, P., Kere, J., and Saarialho-Kere, U. (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152, 1005-1014
13. Uitto, V.J., Airola, K., Vaalamo, M., Johansson, N., Putnins, E., Firth, J. D., Salonen, J., López-Otín, C., Saarialho-Kere, U., and Kähäri, V.-M. (1998) Collagenase-3 (matrix metalloproteinase-3) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152, 1489-1499
14. Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., and López-Otín, C. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269, 16766-16773
15. Heppner, K. J., Matrisian, L. M., Jensen, R. A., and Rodgers, W. H. (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149, 273-282
16. Uría, J. A., Ståhle-Bäckdahl, M., Seiki, M., Fueyo, A., and López-Otín, C. (1997) Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 57, 4882-4888
17. Johansson, N., Airola, K., Grénman, R., Kariniemi, A.-L., Saarialho-Kere, U., and Kähäri, V.-M. (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151, 499-508
18. Airola, K., Johansson, N., Kariniemi, A.-L., Kähäri, V.-M., and Saarialho-Kere, U. (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol. 109, 225-231
19. Johansson, N., Vaalamo, M., Grénman, S., Hietanen, S., Klemi, P., Saarialho-Kere, U., and Kähäri, V.-M. (1999) Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am. J. Pathol. 154, 469-480
20. Uría, J. A., Balbín, M., López, J. M., Alvarez, J., Vizoso, F., Takigawa, M., and López-Otín, C. (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am. J. Pathol. 153, 91-101
21. Murphy, G., and Knäuper, V. (1997) Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15, 511-518
22. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (London) 370, 61-65
23. Sato, H., Kinoshita, T., Takino, T., Nakayama, K., and Seiki, M. (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393, 101-104
24. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. (1997) Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660
25. Cossins, J., Dudgeon, T. J., Catlin, G., Gearing, A. J., and Clements, J. M. (1996) Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228, 494-498
26. Pendas, A. M., Knäuper, V., Puente, X. S., Llano, E., Mattel, M. G., Apte, S., Murphy, G., and López-Otín, C. (1997) Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J. Biol. Chem. 272, 4281-4286
27. Llano, E., Pendas, A., Knäuper, V., Sorsa, T., Salo, T., Salido, E., Murphy, G., Simmer, J., Bartlett, J., and López-Otín, C. (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36, 15101-15108
28. Gomez, D. E., Alonso, D. F., Yoshiji, H., and Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-22
29. Kruger, A., Sanchez Sweatman, O. H., Martin, D. C., Fata, J. E., Ho, A. T., Orr, F. W., Ruther, U., and Khokha, R. (1998) Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene 16, 2419-2423
30. Ahonen, M., Baker, A., and Kähäri, V.-M. (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinaises-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58, 2310-2315
31. Pilcher, B., Dumin, J., Sudbeck, B., Krane, S., Welgus, H., and Parks, W. C. (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457
32. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54, 4791-4797
33. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. (1998) Requirement of specific proteases in cancer cell intravasation as revealed by novel semiquantitative PCR-based assay. Cell 94, 353-362
34. Brooks, P. C., Silletti, S., von Schalscha, T. L, Friedlander, M., and Cheresh, D. A. (1998) Disruption of angiogenesis by PEX, a noncatarytic metalloproteinase fragment with integrin bind-ing activity. Cell 92, 391-400
35. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L., and Matrisian, L. M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. U. S. A. 94, 1402-1407
36. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051
37. Masson, R., Lefebvre, O., Noel, A., Fahime, M. E., Chenard, M. P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J. M., Basset, P., and Rio, M. C. (1998) In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140, 1535-41
38. Guo, H., Zucker, S., Gordon, M. K., Toole, B. P., and Biswas, C. (1997) Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272, 24-27
39. Ito, A., Mukaiyama, A., Itoh, Y., Nagase, H., Thogersen, I. B., Enghild, J. J., Sasaguri, Y., and Mori, Y. (1996) Degradation of interleukin-1β by matrix metalloproteinases. J. Biol. Chem. 271, 14657-14660
40. Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Mover, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J.-L., Warner, J., Willard, D., and Becherer, J. D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature (London) 385, 733-736
41. Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., Docherty, A. J. P., and Murphy, G. (1998) TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39-44
42. Atula, S., Grenman, R., and Syrjänen, S. (1997) Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp. Cell Res. 235, 180-187
43. Skobe, M., and Fusenig, N. E. (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. U. S. A. 95, 1050-1055
44. Hanahan, D., and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364
45. Iozzo, R. V. (1995) Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab. Invest. 73, 157-160
46. Kauppila, S., Saarela, J., Stenbäck, F., Risteli, J., Kauppila, A., and Risteli. L. (1996) Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am. J. Pathol. 148, 539-48
47. Bolon, I., Gouyer, V., Devouassoux, M., Vandenbunder, B., Wernert, N., Moro, D., Brambilla, C., and Brambilla, E. (1995) Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 147, 1298-1310
48. Bolon, I., Brambilla, E., Vandenbunder, B., Robert, C., Lantuejoul, S., and Brambilla, C. (1996) Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab. Invest. 75, 1-13
49. Murray, G. I., Duncan, M. E., O'Neil, P., Melvin, W. T., and Fothergill, J. E. (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2, 461-462
50. Ståhle-Bäckdahl, M., and Parks, W. C. (1993) 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol. 142, 995-1000
51. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85, 683-693
52. Polette, M., Nawrocki, B., Gilles, C., Sato, H., Seiki, M., Tournier, J. M., and Birembaut, P. (1996) MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch. 428, 29-35
53. Patterson, B. C., and Sang, Q. A. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825
54. Lijnen, H. R., Ugwu, F., Bini, A., and Collen, D. (1998) Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37, 4699-702
55. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810
56. Baker, A. H., Zaltsman, A. B., George, S. J., and Newby, A. C. (1998) Divergent effects of tissue inhibitor of metalloprotein-ase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 101, 1478-87
57. Bian, J., Wang, Y., Smith, M. R., Kim, H., Jacobs, C., Jackman, J., Kung, H. F., Colburn, N. H., and Sun, Y. (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17, 1805-11
58. Vincenti, M. P., White, L. A., Schroen, D. J., Benbow, U., and Brinckerhoff, C. E. (1996) Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit. Rev. Eukaryot. Gene Exp. 6, 391-411
59. Benbow, U., and Brinckerhoff, C. (1997) The AP-1 site and MMP gene regulation: What is all the Fuss about? Matrix Biol. 15, 519-526
60. Karin, M., Liu, Z.-G., and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246
61. Angel, P., and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157
62. Lee, J. S., See, R. H., Deng, T., and Shi, Y. (1996) Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol. 16, 4312-4326
63. Doyle, G. A. R., Pierce, R. A., and Parks, W. C. (1997) Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-β site. J. Biol. Chem. 272, 11840-11849
64. Westermarck, J., Seth, A., and Kähäri, V.-M. (1997) Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14, 2651-2660
65. Chiu, R., Angel, P., and Karin, M. (1989) Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59, 979-986
66. Bergelson, S., and Daniel, V. (1994) Cooperative interaction between Ets and AP-1 transcription factors regulates induction of glutalhione S-transferase Ya gene expression. Biochem. Biophys. Res. Commun. 200, 290-297
67. Westermarck, J., Lohi, J Keski-Oja, J., and Kähäri, V.-M. (1994) Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB. Cell Growth Differ. 5, 1205-1213
68. Hu, E., Mueller, E., Oliviero, S., Papaioannou, V. E., Johnson, R., and Spiegelman, B. M. (1994) Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13, 3094-3103
69. Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., and Spiegelman, B. M. (1995) c-fos is required for malignant progression of skin tumors. Cell 82, 721-732
70. Gack, S., Vallon, R., Schaper, J., Ruther, U., and Angel, P. (1994) Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J. Biol. Chem. 269, 10363-10369
71. Levin, W. J., Press, M. F., Gaynor, R. B., Sukhatme, V. P., Boone, T. C., Reissmann, P. T., Figlin, R. A., Holmes, E. C., Souza, L. M., and Slamon, D. J. (1995) Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11, 1261-1269
72. Sharrocks, A. D., Brown, A. L., Ling, Y., and Yates, P. R. (1997) The ETS-domain transcription factor family. Int. J. Biochem. Cell Biol. 12, 1371-1387
73. Carrere, S., Verger, A., Flourens, A., Stehelin, D., and Duterque-Coquillaud, M. (1998) Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene 16, 3261-3268
74. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M. B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. (1994) Stromal expression of c-Etsl transcription factor correlates with tumor invasion. Cancer Res. 54, 5683-5688
75. Wernert, N., Raes, M. B., Lassalle, P., Dehouck, M. P., Gosselin, B., Vandenbunder, B., and Stehelin, D. (1992) c-ets1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140, 119-127
76. Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S., and Fujinaga, K. (1996) A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 12, 221-227
77. Buttice, G., Duterque Coquillaud, M., Basuyaux, J. P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996) Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13, 2297-2306
78. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. (1996) Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol. Chem. 271, 10672-10680
79. Minden, A., and Karin, M. (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333, F85-104
80. Robinson, M. J., and Cobb, M. H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186
81. Lewis, T. S., Shapiro, P. S., and Ahn, N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-129
82. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., and Ahn, N. G. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970
83. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852
84. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., and Yoshida, O. (1995) Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55, 4182-4187
85. Sivaraman, V., Wang, H., Nuovo, G., and Malbon, C. (1997) Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99, 1478-1483
86. Khosravi-Far, R., Campbell, S., Rossman, K. L., and Der, C. J. (1998) Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv. Cancer Res. 72, 57-107
87. Leppä, S., Saffrich, R., Ansorge, W., and Bohmann, D. (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 17, 4404-4413
88. Price, M. A., Cruzalegui, F. H., and Treisman, R. (1996) The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J. 15, 6552-6563
89. O'Hagan, R. C., Tozer, R. G., Symons, M., McCormick, F., and Hassell, J. A. (1996) The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13, 1323-1333
90. Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R. J. (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671-1674
91. Schaeffer, H. J., Catling, A. D., Eblen, S. T., Collier, L. S., Krauss, A., and Weber, M. J. (1998) MPI: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668-1671
92. Kim, S. J., Lafyatis, R., Kim, K. Y., Angel, P., Fujiki, H., Karin, M., Sporn, M. B., and Roberts, A. B. (1990) Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases. Cell Regul. 1, 269-278
93. Frost, J. A., Geppert, T. D., Cobb, M. H., and Feramisco, J. R. (1994) A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. U. S. A. 91, 3844-3848
94. Rutter, G. A., White, M. R., and Tavare, J. M. (1995) Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curr. Biol. 5, 890-899
95. Korzus, E., Nagase, H., Rydell, R., and Travis, J. (1997) The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 272, 1188-1196
96. Reifel-Miller, A. E., Conarty, D. M., Valasek, K. M., Iversen, P. W., Burns, D. J., and Birch, K. A. (1996) Protein kinase C isozymes differentially regulate promoters containing PEA-3/ 12-O-tetradecanoylphorbol-13-acetate response element motifs. J. Biol. Chem. 271, 21666-21671
97. Reunanen, N., Westermarck, J., Häkkinen, L., Holmström, T. H., Elo, I., Eriksson, J. E., and Kähäri, V.-M. (1998) Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273, 5137-5145
98. Westermarck, J., Holmström, T. H., Ahonen, M., Eriksson, J. E., and Kähäri, V.-M. (1998) Enhancement of collagenase-1-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 17, 547-557
99. Ridley, S. H., Sarsfield, S. J., Lee, J. C., Bigg, H. F., Cawston, T. E., Taylor, D. J., DeWitt, D. L., and Saklatvala, J. (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158, 3165-3173
100. Ravanti, L., Heino J., López-Otín, C., and Kähäri, V.-M. (1999) Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 274, 2446-2455
101. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. (1997) Regulation of 92 kDa type IV collagenase expression of the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493
102. Simon, C., Goepfert, H., and Boyd, D. (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135-1139
103. Holmström, T. H., Chow, S. C., Elo, I., Coffey, E. T., Orrenius, S., Sistonen, L., and Eriksson, J. E. (1998) Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 160, 2626-2636
104. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331
105. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., and Akhurst, R. J. (1996) TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542
106. Westermarck, J., Häkkinen, L., Fiers, W., and Kähäri, V.-M. (1995) TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts. J. Invest. Dermatol. 105, 197-202
107. Pender, S., Fell, J., Chamow, S., Ashkenazi, A., and MacDonald, T. (1998) A p55 TNF receptor immunoadhesion prevents T cell-mediated intenstinal injury by inhibiting matrix metalloproteinase production. J. Immunol. 160, 4098-4103
108. Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., and Fabbro, D. (1996) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med. 2, 668-675
109. Shiozawa, S., Shimizu, K., Tanaka, K., and Hino, K. (1997) Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J. Clin. Invest. 99, 1210-1216
110. Huang, C., Ma, W. Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. (1997) Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. U. S. A. 94, 5826-5830
111. Hua, J., and Muschel, R. J. (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56, 5279-5284
112. Hasegawa, S., Koshikawa, N., Momiyama, N., Moriyama, K., Ichikawa, Y., Ishikawa, T., Mitsuhashi, M., Shimada, H., and Miyazaki K. (1998) Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int. J. Cancer76, 812-6
113. Brown P. D. (1998) Synthetic inhibitors of matrix metalloproteinases. In Matrix Metalloproteinases (Parks, W. C., and Mecham, R. P., eds) pp. 243-262, Academic Press: San Diego
114. Kähäri, V.-M., and Saarialho-Kere, U. (1999) Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med. 31, 34-45
115. Fife, R. S., Rougraff, B. T., Proctor, C., and Sledge, G. W., Jr. (1997) Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J. Lab. Clin. Med. 130, 530-534